Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma

Fig. 5

Immune cell infiltration landscapes in high- and low-risk patients with HNSC in TCGA-HNSC cohort. A Scaled immune cell infiltration proportions in high- and low-risk patients. The proportions were estimated by CIBERSORT through mRNA expression matrix (scaled by log2(TPM + 1)); B Correlation matrix for immune cells. C Differences of immune cell infiltrations between high- and low-risk patients. D Differences of immune-associated genes between high- and low-risk patients

Back to article page